GlassScriptPhysician profile
Veronica R Rivera
NPI 1477734754
$1,728.85
in general payments reported to CMS, 2019-2025
12 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.13 · 2020: $45.79 · 2021: $202 · 2022: $145 · 2023: $628 · 2024: $307 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,259 · Education: $45.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,258.90 |
| Education | $45.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $742.83 | 2023-2025 | |
| Exeltis, USA INC. | $267.93 | 2023-2024 | Tyblume |
| Therapeuticsmd, INC. | $260.51 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $216.54 | 2024-2025 | Gemtesa, Myfembree |
| Pfizer INC. | $50.56 | 2021-2024 | |
| Millicent US INC | $44.42 | 2024-2025 | Femlyv |
| Organon LLC | $39.44 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $36.92 | 2019-2020 | |
| Abbvie INC. | $20.87 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.13 | 2019 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Mylan Pharmaceuticals INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.